Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...

Large-cap stocks, valued over $10 billion, offer stability and are considered safer during bear markets. Investing in large-cap exchange-traded funds (ETFs) like the Vanguard S&P 500 ETF provides ...

Bowel cancer can start in the large bowel (colon cancer) or back passage (rectal cancer). It is also called colorectal cancer. This section is about treatment for colon cancer that hasn't spread to ...

Inflammatory bowel disease (IBD) is a group of intestinal disorders that cause prolonged inflammation of the digestive tract. It can include ulcerative colitis (UC) or Crohn’s disease.

Large-growth funds posted strong gains in 2024, thanks partly to the artificial intelligence boom. Despite slipping in December, the average large-growth fund beat the broader market last year.

a type of chronic inflammatory bowel disease (IBD). The drug, branded as Omvoh, is already approved in the U.S. to treat moderate-to-severe active ulcerative colitis, another type of IBD.

The study found that drinking an additional 20g of alcohol a day, equivalent to a large glass of wine, increased bowel cancer risk by 15%. Consuming more than 30g of red and processed meat daily ...

"And even then it was too late - a large bowel tumour and eight lung tumours too late." “She was all too aware that many people ignore the invite and put off their test, a decision that can ...

Bowel cancer is often referred to as colorectal cancer. “When we say colorectal cancer, we mainly mean cancer of the colon, which is the large intestine, but it also includes rectal cancer and ...

Hundreds of thousands more people will be sent a home-testing kit that can help to detect signs of bowel cancer, as the NHS expands its lifesaving screening programme to those aged 50 in England.

All 50-74-year-olds in England will now receive a home-testing kit for bowel cancer every two years. NHS England has been posting the faecal-immunochemical test (Fit) to all 54-74-year-olds since ...